Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
about
Hemolytic uremic syndrome: new developments in pathogenesis and treatmentHemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimersDo the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice.Molecular Basis of Differential B-Pentamer Stability of Shiga Toxins 1 and 2Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the GutAssociation of Escherichia coli O157:H7 tir polymorphisms with human infection.Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks.Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattleAnalysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence.Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coliAdvances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.Shiga toxin pathogenesis: kidney complications and renal failure.Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.New high-affinity monoclonal antibodies against Shiga toxin 1 facilitate the detection of hybrid Stx1/Stx2 in vivo.Interaction of ricin and Shiga toxins with ribosomesStructure, biological functions and applications of the AB5 toxins.Different classes of antibiotics differentially influence shiga toxin production.Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.Association of nucleotide polymorphisms within the O-antigen gene cluster of Escherichia coli O26, O45, O103, O111, O121, and O145 with serogroups and genetic subtypesIdentification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae.Shiga toxin subtypes display dramatic differences in potencyFailure of manganese to protect from Shiga toxin.Shiga toxin 1 is more dependent on the P proteins of the ribosomal stalk for depurination activity than Shiga toxin 2Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.Multiple antibiotic resistances among Shiga toxin producing Escherichia coli O157 in feces of dairy cattle farms in Eastern Cape of South Africa.Pathogenic potential to humans of bovine Escherichia coli O26, Scotland.Colonization of Beef Cattle by Shiga Toxin-Producing Escherichia coli during the First Year of Life: A Cohort Study.Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse ModelBinding of adenine to Stx2, the protein toxin from Escherichia coli O157:H7.Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year periodEvolution of the Stx2-encoding prophage in persistent bovine Escherichia coli O157:H7 strains.Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants.Different Effects of Six Antibiotics and Ten Traditional Chinese Medicines on Shiga Toxin Expression by Escherichia coli O157:H7
P2860
Q24613517-46EB526A-5585-46C7-A3C4-CD1E385F7535Q24669689-26EE778D-6A80-4D73-8788-51D1460AD27AQ26858938-248EE460-A060-4474-8332-2C4658EC32FEQ27317705-D08412E5-8B54-4C4E-A44E-FA2675C9B760Q27334562-BAA0EA2D-DB60-4C88-9731-56E39F841851Q27666433-46D8BE3C-B10D-4074-81E5-22AE621C3D2EQ28829014-3F7E33A0-1ED9-465B-94B4-00A19C53B8F7Q33295079-2BC67EB0-8481-4FD1-B558-0F6578180F19Q33308321-53AFA641-2AE1-4353-A2E1-3B665AFA020AQ33364280-545F6E41-D34D-465E-ABF9-D25E10D8242EQ33376766-FA2746DE-2156-4534-A5C6-4D6EE1FCF2E2Q33385189-5B4822C9-6C9D-44FD-9E81-229B4CD10E1CQ33388849-8E02628E-48B3-4F30-BA53-39B4208C4F70Q33392316-27DC9A2B-6EA6-498F-A48C-0C1F4FB89BF1Q33394010-49AE12F7-8B8A-4D02-8EDC-A8E63C989202Q33395449-1FB452DA-505B-4C5C-896C-E151331F8CB5Q33397541-CA829334-0B45-4125-9E41-D79A034BB80DQ33426863-DBA58E8B-D329-4AD0-8F7A-F114C7486D09Q33426867-98F94F04-997F-4880-92E2-A18E997211B5Q33734620-568A9F0B-D2AF-4702-8F88-79C34EAFA280Q33921062-B02E96D2-36BB-4F5D-B11D-57311143D738Q34102115-14A6DF9A-4068-454B-93C7-116359F25579Q34108726-72217A70-49AC-408B-991F-D3FB99497817Q34231661-3FA5A747-2DED-46D7-99F3-463DA0AE14A4Q34338238-AC3F4E5C-CAD7-48AB-86DE-C742B5435CFEQ34663367-7EC4EA08-53A7-42BF-96F3-10FA59F6C078Q34739913-DACCE61A-C44E-40DC-96C2-9EE96B2E9585Q34854599-D2D6663E-709F-455C-AB25-C7D718F48855Q35501790-87EDF345-4126-412D-A4F5-C881FDC69BF7Q35673972-0DD12FB2-EED5-48EE-AF52-548587BCEAA7Q35811254-4EA22B3F-BB4B-4203-9EF3-AFF533FC5356Q35844593-22919E26-7962-4081-8DF7-D27288931E81Q35915609-E26EC658-6712-421E-BB83-5C1847A811ACQ36068651-874F7C67-BADD-4174-A190-5F6EAAB707A5Q36137954-DD1291C2-DCA8-42EF-9C1F-8EA2F8DBF594Q36459565-4EDA0840-BABF-4266-B36B-976A837996ACQ36599977-30C7E38C-1ED4-47A8-B08D-E74BB7BBEF9AQ36667351-3E8DE659-84DF-4A06-AFC4-40897F711965Q37036097-CC1767C0-DBAE-4507-8A4E-F308B88AE43BQ37061361-C6BA698B-6DC7-4481-8481-0D3E4B7217D9
P2860
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
@ast
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
@en
type
label
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
@ast
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
@en
prefLabel
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
@ast
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
@en
P2093
P1433
P1476
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
@en
P2093
Fletcher B Taylor
Nathaniel D Denkers
Richard L Siegler
Theodore J Pysher
Tom G Obrig
Vernon L Tesh
P2888
P356
10.1007/S00467-002-1035-7
P577
2003-01-10T00:00:00Z
P6179
1075235454